- Home
- MTN vs INDV Comparison
MTN vs INDV Comparison
Compare MTN & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTN | INDV |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.7B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MTN | INDV |
|---|---|---|
| Price | $128.42 | $37.64 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $162.58 | N/A |
| AVG Volume (30 Days) | 695.9K | ★ 2.0M |
| Earning Date | 06-04-2026 | 06-08-2026 |
| Dividend Yield | ★ 7.27% | N/A |
| EPS Growth | 24.05 | ★ 8100.00 |
| EPS | 0.65 | ★ 0.69 |
| Revenue | ★ $2,964,347,000.00 | $1,239,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.42 | N/A |
| P/E Ratio | $195.22 | ★ $54.72 |
| Revenue Growth | 2.74 | ★ 4.29 |
| 52 Week Low | $118.51 | $11.49 |
| 52 Week High | $175.51 | $41.00 |
Technical Indicators
Market Signals| Indicator | MTN | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 58.25 |
| Support Level | $125.05 | $29.71 |
| Resistance Level | $128.37 | $37.83 |
| Average True Range (ATR) | 3.46 | 1.15 |
| MACD | 0.75 | -0.32 |
| Stochastic Oscillator | 81.37 | 35.77 |
Price Performance
Historical ComparisonAbout MTN Vail Resorts Inc.
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).